Market revenue in 2023 | USD 4,622.5 million |
Market revenue in 2030 | USD 7,818.0 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Personalized nutrition & wellness |
Fastest growing segment | PM Therapeutics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.
Personalized nutrition & wellness was the largest segment with a revenue share of 35.48% in 2023. Horizon Databook has segmented the Saudi Arabia personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.
Extensive research studies involving sequencing can help expand the usage of advanced sequencing techniques in Saudi Arabia. Government initiatives such as the Saudi Genome program aim to establish a genetic database, document the first Saudi genetic map of the population, and reduce the incidence of genetic diseases in the country.
Another initiative is KAUST’s Smart Health Initiative, which has collaborated across the country to help drive personalized medicine. Such initiatives would enhance the country’s position in the field of genetic research for diseases and personalized medicine.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia personalized medicine market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account